Golden Growers Cooperative — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Golden Growers Cooperative filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.28M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $62.00M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $88.02M | Sep 17, 2025 |
| FY2024 | Dec 31, 2022 | $107.41M | Sep 17, 2025 |
| FY2023 | Dec 31, 2021 | $89.57M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $50.56M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $54.30M | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | $50.10M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $49.89M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $52.14M | Mar 8, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.78M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $5.60M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $5.21M | Sep 17, 2025 |
| FY2024 | Dec 31, 2022 | $6.17M | Sep 17, 2025 |
| FY2023 | Dec 31, 2021 | $7.89M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $5.39M | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | $7.05M | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | $6.34M | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | $9.15M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $4.70M | Mar 8, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($396.0K) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($396.0K) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($281.0K) | Sep 17, 2025 |
| FY2024 | Dec 31, 2022 | ($410.0K) | Sep 17, 2025 |
| FY2023 | Dec 31, 2021 | ($384.0K) | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | ($350.0K) | Mar 8, 2023 |
| FY2021 | Dec 31, 2019 | ($458.0K) | Mar 8, 2022 |
| FY2020 | Dec 31, 2018 | ($542.0K) | Mar 5, 2021 |
| FY2019 | Dec 31, 2017 | ($474.0K) | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | ($753.0K) | Mar 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2012 | $6.0K | Mar 31, 2015 |
| FY2011 | Aug 31, 2009 | $14.0K | Mar 30, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.28M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $24.90M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $26.82M | Sep 17, 2025 |
| FY2023 | Dec 31, 2022 | $27.86M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $27.95M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $25.96M | Mar 8, 2022 |
| FY2020 | Dec 31, 2019 | $26.59M | Mar 5, 2021 |
| FY2019 | Dec 31, 2018 | $26.05M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $26.47M | Mar 8, 2019 |
| FY2017 | Dec 31, 2016 | $23.84M | Mar 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $1.31M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $2.10M | Sep 17, 2025 |
| FY2023 | Dec 31, 2022 | $2.15M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.60M | Mar 8, 2023 |
| FY2022 | Dec 31, 2020 | $3.55M | Mar 8, 2023 |
| FY2022 | Dec 31, 2019 | $3.23M | Mar 8, 2023 |
| FY2021 | Dec 31, 2018 | $2.40M | Mar 8, 2022 |
| FY2020 | Dec 31, 2017 | $6.26M | Mar 5, 2021 |
| FY2019 | Dec 31, 2016 | $2.79M | Mar 6, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 0 | Mar 8, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 8, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 8, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 0 | Mar 8, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 8, 2023 |
| FY2022 | Dec 31, 2020 | 0 | Mar 8, 2023 |